Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Carrier-mediated transport of the folic acid analogue, methotrexate, in the L1210 leukemia cell.

× No keyword cloud information.

64 in total

1. The membrane transport and polyglutamation of pralatrexate: a new-generation dihydrofolate reductase inhibitor.

Authors: Michele Visentin; Ersin Selcuk Unal; Rongbao Zhao; I David Goldman
Journal: Cancer Chemother Pharmacol Date: 2013-07-24 Impact factor: 3.333

Review 2. Polyglutamation of methotrexate. Is methotrexate a prodrug?

Authors: B A Chabner; C J Allegra; G A Curt; N J Clendeninn; J Baram; S Koizumi; J C Drake; J Jolivet
Journal: J Clin Invest Date: 1985-09 Impact factor: 14.808

3. Structure and function of the reduced folate carrier a paradigm of a major facilitator superfamily mammalian nutrient transporter.

Authors: Larry H Matherly; Zhanjun Hou
Journal: Vitam Horm Date: 2008 Impact factor: 3.421

Review 4. Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissues.

Authors: Rongbao Zhao; Larry H Matherly; I David Goldman
Journal: Expert Rev Mol Med Date: 2009-01-28 Impact factor: 5.600

5. The outward transport of cortisol by mammalian cells in vitro.

Authors: S R Gross; L Aronow; W B Pratt
Journal: J Cell Biol Date: 1970-01 Impact factor: 10.539

6. The kinetics of methotrexate distribution in spontaneous canine lymphosarcoma.

Authors: R J Lutz; R L Dedrick; J A Straw; M M Hart; P Klubes; D S Zaharko
Journal: J Pharmacokinet Biopharm Date: 1975-04

7. Effects of amino acids on the transport and cytotoxicity of melphalan by human bone marrow cells and human tumor cells.

Authors: M Dufour; L C Panasci; J St Germain; L Boulet
Journal: Cancer Chemother Pharmacol Date: 1985 Impact factor: 3.333

8. The mechanism of 5-methyltetrahydrofolate transport by human erythrocytes.

Authors: R F Branda; B K Anthony; H S Jacob
Journal: J Clin Invest Date: 1978-05 Impact factor: 14.808

9. Pharmacokinetic and clinical studies of 24-h infusions of high-dose methotrexate.

Authors: H J Cohen; N Jaffe
Journal: Cancer Chemother Pharmacol Date: 1978 Impact factor: 3.333

10. Long-duration intracavitary infusion of methotrexate with systemic leucovorin protection in patients with malignant effusions.

Authors: S B Howell; B B Chu; W E Wung; B M Metha; J Mendelsohn
Journal: J Clin Invest Date: 1981-04 Impact factor: 14.808